Thyroid hormone alterations during and after cardiopulmonary bypass

Area of Science:

• Endocrinology
• Cardiovascular Surgery
• Thyroid Hormone Metabolism

Background:

• Thyroid hormones significantly influence cardiovascular function, affecting heart rate, contractility, and myocardial oxygen demand.
• Cardiopulmonary bypass (CPB) is known to disrupt endocrine homeostasis and can lead to postoperative hemodynamic alterations.

Purpose of the Study:

• To investigate the relationship between cardiopulmonary bypass and subsequent changes in thyroid function.
• To quantify alterations in key thyroid hormone levels following CPB procedures.

Main Methods:

• Prospective study involving 20 patients undergoing cardiopulmonary bypass.
• Blood samples collected preoperatively and at multiple time points during and after CPB.
• Radioimmunoassay and competitive immunoassay used to measure total thyroxine (TT4), total triiodothyronine (TT3), free thyroxine (fT4), free triiodothyronine (fT3), thyroid-stimulating hormone (TSH), thyroid-binding globulin (TBG), and albumin.

Main Results:

• Significant depression in circulating levels of TT4, TT3, and fT3 observed up to 24 hours post-CPB (P < 0.05).
• Thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels remained within normal physiological ranges throughout the study period.
• These findings indicate a transient impairment of thyroid hormone metabolism following CPB.

Conclusions:

• Cardiopulmonary bypass demonstrably affects thyroid hormone metabolism.
• A transient depression in circulating TT4, TT3, and fT3 is a characteristic finding after CPB.
• Further research may explore the clinical implications of these transient hormonal shifts.